What We Do
Commitment to Innovation
Our company understands that severe pain is a global challenge and that existing medications provide patients and their families with inadequate care.
Amalgent is developing combination drugs that will dramatically improve the safety of existing therapeutics.
Drug Development and Testing
Amalgent is a clinical-stage pain management company that is developing innovative oral pain therapeutics for the US market.
Additional combinations, geographies and methods of administration will follow.
Our Products
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.